Inventor
Li Xing
Inventor
Lexington, MA, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds24%
A61KPreparations for medical, dental or toiletry purposes16%
A01KAnimal husbandry4%
A23KFodder4%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers4%
A01NPreservation of bodies of humans or animals or plants or parts thereof3%
A01PBiocidal, pest repellant, pest attractant or plant growth regulatory activity of chemical compounds or preparations3%
H04NPictorial communication, e.g. television3%
A61BDiagnosis1%
PatentTitleYear
11,081,553Method of forming split gate memory cells202110,994,133Methods for enhancing and modulating reversible and irreversible electroporation lesions by manipulating pulse waveforms202110,985,687Common mode noise cancellation and DC ripple reduction techniques202110,836,772DNA polymerase IIIC inhibitors and use thereof202010,822,341Pyrazolo[1,5-a]pyrazin-4-yl derivatives202010,815,213Bruton's tyrosine kinase inhibitors202010,723,741DNA polymerase IIIC inhibitors and use thereof202010,493,129Use of fibroblast growth factor 2201910,463,675Aminopyrimidinyl compounds201910,426,135Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof201910,385,036Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof201910,336,748Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof201910,308,615Heterocyclic compounds as inhibitors of Vanin-1 enzyme201910,266,513Bruton's tyrosine kinase inhibitors201910,227,346Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof201910,144,738Pyrazolo[1,5-A]PYRAZIN-4-YL derivatives20189,670,201'Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof'20179,663,526'Aminopyrimidinyl compounds'20179,284,283'Macrocyclic compounds for modulating IL-17'20168,686,185'Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts'20147,629,363'Diaryl substituted pyridinones'20097,259,266'Benzopyran compounds useful for treating inflammatory conditions'20077,067,540'Substituted pyridinones'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2007Patents assigned to PHARMACIA CORP (2)· patent assignee history
2006–2009Based in Chesterfield, MO, US· patent location history
2009–2020Patents assigned to PFIZER (13)· patent assignee history
2014Patents assigned to CHO JAE YOUNG (1)· patent assignee history
2016–2020Based in Lexington, MA, US· patent location history
2019Patents assigned to BEIJING INST OF MICROBIOLOGY AND EPIDEMIOLOGY (1)· patent assignee history
2020Patents assigned to ACURX PHARMACEUTICALS LLC (2)· patent assignee history
2021Based in Shanghai, CN· patent location history
2021Based in Palo Alto, CA, US· patent location history
2021Based in South Windsor, CT, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PFIZER | 13 | 2009–2020 |
| ACURX PHARMACEUTICALS LLC | 2 | 2020 |
| PHARMACIA CORP | 2 | 2006–2007 |
| BEIJING INST OF MICROBIOLOGY AND EPIDEMIOLOGY | 1 | 2019 |
| CHO JAE YOUNG | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lexington, Massachusetts, US | 15 | 2016–2020 |
| Chesterfield, MO, US | 3 | 2006–2009 |
| Shanghai, CN | 1 | 2021 |
| Palo Alto, California, US | 1 | 2021 |
| South Windsor, CT, US | 1 | 2021 |